Clinical characteristics and economic costs of patients with painful neuropathic disorders.
about
Oral nonsteroidal anti-inflammatory drugs for neuropathic painCombination pharmacotherapy for the treatment of neuropathic pain in adultsOpioids for neuropathic painNeuropathic pain: a practical guide for the clinicianRecommendations for the pharmacological management of neuropathic pain: an overview and literature updateCannabinoids for chronic neuropathic painNeuropathic low back pain in clinical practiceThe diagnosis and management of neuropathic pain in daily practice in Belgium: an observational studyMethadone for neuropathic pain in adultsUsing electronic health records data to identify patients with chronic pain in a primary care setting.Chronic pain and health care spending: an analysis of longitudinal data from the Medical Expenditure Panel Survey.Is preoperative occupation related to long-term pain in patients operated for lumbar disc herniation?A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patientsThe need for knowledge translation in chronic pain.Clinical characteristics, patient-reported outcomes, and previous therapeutic management of patients with uncontrolled neuropathic pain referred to pain clinicsTreatment considerations for elderly and frail patients with neuropathic painA cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings.Anatomical study of middle cluneal nerve entrapmentHealth care utilization and expenditures among Medicaid beneficiaries with neuropathic pain following spinal cord injury.Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings.Predictive value of lidocaine for treatment success of oxcarbazepine in patients with neuropathic pain syndromeMultivariate analysis of chronic pain patients undergoing lidocaine infusions: increasing pain severity and advancing age predict likelihood of clinically meaningful analgesia.Smoked cannabis for chronic neuropathic pain: a randomized controlled trial.Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study.The prevalence of neuropathic pain: clinical evaluation compared with screening tools in a community population.Differences between opioids: pharmacological, experimental, clinical and economical perspectivesGabapentin for chronic neuropathic pain in adults.Management of chronic neuropathic pain: a protocol for a multiple treatment comparison meta-analysis of randomised controlled trials.Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting.The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation.Progesterone prevents development of neuropathic pain in a rat model: Timing and duration of treatment are critical.Efficacy of piroxicam patch compared to lidocaine patch for the treatment of postherpetic neuralgia.Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression.Duloxetine in the management of diabetic peripheral neuropathic pain.Injury-specific promoters enhance herpes simplex virus-mediated gene therapy for treating neuropathic pain in rodentsPain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational StudyBotulinum Toxin-A for Painful Diabetic Neuropathy: A Meta-Analysis.Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer.Brain stimulation in the treatment of chronic neuropathic and non-cancerous pain.Characteristics and healthcare costs of patients with fibromyalgia syndrome
P2860
Q24202080-41FEF753-E830-4ECA-9A83-DCA3F03B9B85Q24235158-9155A72C-9BD3-491F-B44C-AB329F597D73Q24245218-53822BE1-5D1F-4C63-B69C-E6DF33861823Q24553796-802F2259-DB55-493F-B43E-01412A7FD7B6Q24616897-85AFAD4A-E8C6-407D-A3D2-089FE21A9786Q26472068-8EF88B3C-4305-4D5F-9F02-B490B8B4853FQ28073412-E57D5A03-A8A9-4A43-A52C-3D10A3B1D62BQ28218796-5501180F-5A22-4D58-B827-EB816099CDF4Q29994484-8C993E5E-C7E3-4F41-A679-7A63B2B4EA8CQ30658465-F4FBE451-E383-4D7C-A4DD-D5610EC4E95AQ30871976-39AB6FD9-C135-4D22-8AC0-BE1297293C4FQ33303391-9EED050E-960E-4D0F-9E91-505363EC869BQ33476547-E33B5B59-DD41-46E1-802B-49AACB9428C4Q33562393-384F35B0-0DAF-4342-AC33-ADA8AFCAEFBDQ33635047-3A717123-CD31-4798-9A8A-5455E42E4C12Q33747265-917C19FE-C8BA-4C9A-BE20-5357AC7981E3Q33798640-EA177A34-EEBA-49F3-AC12-2283CA710CA1Q33812533-BAE86DA1-8EA3-4A53-AD96-AFD858992107Q33857779-1BD9F120-2F01-4941-808C-3A8F5A5FA826Q33880187-054AC72F-5732-4E19-BA7E-B3EBEF3AB8BFQ33938147-A24A27CA-BCB4-4075-97C3-AB7E1C3DDDD1Q34057714-A92F864F-DDFF-47BD-AEF2-CD2024F3B15CQ34134958-BCDFEAB6-9C62-4C43-8645-A8810631E5CCQ34186481-3EF7721D-ECF4-4C9B-8DE6-4FA74E39BE54Q34244816-4FB761FC-CCE5-46F0-A85D-77AE12613A78Q34272502-AF7D45FE-8FEE-44E5-8DA4-89F3DBA4C64CQ34557703-563CC32D-2AF7-4498-92C2-AF5E8513BE52Q34573490-A153F995-14C5-448F-B5C1-08C4B45BC07CQ34753719-3AF04BC2-F7C2-4C94-900B-99D9EB9701F6Q34871826-9D9B0860-4039-4FB0-8054-5F4DD8807EBBQ34895372-5FD5CED1-2455-4915-83DC-71CCBA12AB5DQ35089676-EDC34AE4-974F-43A5-A9C8-01AD6F8C7187Q35118914-BB5151AD-536B-4DCD-AE33-215664947710Q35147185-9BE8A60E-BFCE-4364-89BE-A3A3B874DEEAQ35155806-F0336A90-DB3E-458D-A19A-9F8B6B35116EQ35402169-724EAB03-AA3D-47B6-A81F-711F90C25D6FQ35584564-537C95DA-B40D-4A26-8185-1ABF237CED79Q35852412-9163984A-5045-430C-A94C-ACAB1853E25FQ35947261-057726D0-6438-40D8-A416-034636F48D62Q36088604-17D072F4-317C-4B5C-A0B5-A4FF7DA1CFF8
P2860
Clinical characteristics and economic costs of patients with painful neuropathic disorders.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clinical characteristics and e ...... painful neuropathic disorders.
@en
type
label
Clinical characteristics and e ...... painful neuropathic disorders.
@en
prefLabel
Clinical characteristics and e ...... painful neuropathic disorders.
@en
P2093
P1433
P1476
Clinical characteristics and e ...... painful neuropathic disorders.
@en
P2093
Ariel Berger
Ellen M Dukes
Gerry Oster
P304
P356
10.1016/J.JPAIN.2003.12.004
P577
2004-04-01T00:00:00Z